Clinical Trial

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Investigator
Complete title:
Technology-Enhanced Acceleration of Germline Evaluation for Therapy - TARGET study
Trial phase:
Phase N/A
Study ID:
NCT04447703
Local study ID:
RG1121040
Summary:
This trial performs user testing of a mobile-friendly patient history collection and genetic education tool to improve healthcare providers` understanding of prostate cancer genetic testing. This trial also compares traditional genetic counseling versus a web-based genetic education (WBGE) tool to provide information about genetic testing to men with prostate cancer. The WBGE tool has educational modules on genetic counseling and testing, as well as a patient history collection tool to help providers learn which patients may carry genetic mutations and may be considered for genetic counseling and genetic testing. The purpose of this research is to use technology to deliver information on genetic testing for prostate cancer to patients to help them decide whether or not to receive genetic testing.
Trial keywords:
Prostate Cancer
Enrollment status:
Recruiting
Trial eligibility
** For Eligibility information, please click on the "Look up trial at NIH" link above **
Other eligibility criteria may apply.
Trial exclusions
Other exclusion criteria may apply.
Learn more

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Contact us
phone 1-800-606-7800
Toll-free